Abbott and Dexcom have agreed to settle all of their remaining international legal disputes over patents related to their ...

and a continuous glucose monitor (CGM) has been instrumental in achieving that. Unless you’re an advocate for health tech or a diabetic like me, you may not have heard of Dexcom or Abbott ...

is proud to announce that the Dexcom G7 Continuous Glucose Monitoring (CGM) System has now been added to the Alberta Drug Benefit List. In addition, the Alberta government has expanded the ...

Dexcom is a developer and marketer of continuous glucose monitoring (CGM ... Dexcom Share System which allows remote monitoring, and the Dexcom CLARITY software which is a diabetes management ...

Bengaluru: Abbott Laboratories and DexCom said on Monday they have reached an agreement to settle all patent disputes between them related to continuous glucose monitoring devices. The agreement ...

Bernstein analyst Lee Hambright maintained a Buy rating on Dexcom (DXCM – Research Report) yesterday and set a price target of $86.00. The ...

This week, Dexcom became the first medical device company to integrate generative AI into a continuous glucose monitor. The company added generative AI to its Stelo glucose monitor, which it began ...

Dexcom is a developer and marketer of continuous glucose monitoring (CGM) systems for people with diabetes ... Dexcom G7 which is user-friendly and known for its accuracy, Dexcom Share System which ...